Durable response for ampullary and duodenal adenocarcinoma with a nab-paclitaxel plus gemcitabine ± cisplatin combination.

Putao CenCurtis J WraySonglin ZhangNirav C ThosaniBrian Cuong DinhAnneliese GonzalezVirginia MohlereJohn Steven Bynon

Published in: Cancer medicine (2019)

Nab-paclitaxel plus gemcitabine with or without cisplatin should be investigated as a standard-of-care chemotherapy regimen for patients with ampullary adenocarcinoma and duodenal adenocarcinoma.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
advanced non small cell lung cancer
healthcare
palliative care
quality improvement